99 related articles for article (PubMed ID: 11306790)
21. The effects of erdosteine, N-acetylcysteine, and vitamin E on nicotine-induced apoptosis of pulmonary cells.
Demiralay R; Gürsan N; Erdem H
Toxicology; 2006 Feb; 219(1-3):197-207. PubMed ID: 16377052
[TBL] [Abstract][Full Text] [Related]
22. Comparative pharmacodynamics of telithromycin and clarithromycin with Streptococcus pneumoniae and Staphylococcus aureus in an in vitro dynamic model: focus on clinically achievable antibiotic concentrations.
Alferova IV; Vostrov SN; Portnoy YA; Lubenko IY; Zinner SH; Firsov AA
Int J Antimicrob Agents; 2005 Sep; 26(3):197-204. PubMed ID: 16122914
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial.
Dal Negro RW; Visconti M; Turco P
Pulm Pharmacol Ther; 2015 Aug; 33():47-51. PubMed ID: 26116425
[TBL] [Abstract][Full Text] [Related]
24. [Antimicrobial activity of clarithromycin and its effect on bacterial adherence to medical material].
Nakashio S; Susa C; Qiu S; Kijima A; Iwasawa H; Shimomura H; Kanemitsu K; Hori S; Mizushima Y; Shimada J
Jpn J Antibiot; 1993 Jun; 46(6):428-36. PubMed ID: 8360978
[TBL] [Abstract][Full Text] [Related]
25. Erdosteine improves oxidative damage in a rat model of renal ischemia-reperfusion injury.
Gurel A; Armutcu F; Cihan A; Numanoglu KV; Unalacak M
Eur Surg Res; 2004; 36(4):206-9. PubMed ID: 15263825
[TBL] [Abstract][Full Text] [Related]
26. Protective effects of erdosteine against nephrotoxicity caused by gamma radiation in male albino rats.
Elkady AA; Ibrahim IM
Hum Exp Toxicol; 2016 Jan; 35(1):21-8. PubMed ID: 25716170
[TBL] [Abstract][Full Text] [Related]
27. The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?
El Haj C; Murillo O; Ribera A; Garcia-Somoza D; Tubau F; Cabellos C; Cabo J; Ariza J
Med Microbiol Immunol; 2017 Feb; 206(1):31-39. PubMed ID: 27639707
[TBL] [Abstract][Full Text] [Related]
28. Dual effects of erdosteine on hemostasis via its different metabolites in young rats.
Arica V; Tutanc M; Ozturk OH; Arica S; Basarslan F; Erden ES; Oktar S; Kaya H
Hum Exp Toxicol; 2011 Oct; 30(10):1644-8. PubMed ID: 21247989
[TBL] [Abstract][Full Text] [Related]
29. Staphylococcus aureus and Escherichia coli adhesion to human cells is reduced by sub-MICs of gemifloxacin.
Braga PC; Dal SM; Woodnutt G
J Chemother; 2002 Feb; 14(1):41-6. PubMed ID: 11892898
[TBL] [Abstract][Full Text] [Related]
30. Effect of erdosteine and its metabolites on tracheobronchial mucus production and transport.
Scuri R; Giannetti P; Paesano A
Drugs Exp Clin Res; 1988; 14(11):693-8. PubMed ID: 3246214
[TBL] [Abstract][Full Text] [Related]
31. Effect of moxifloxacin on bacterial pathogenicity factors in comparison with amoxicillin, clarithromycin and ceftriaxone.
Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
J Chemother; 2004 Feb; 16(1):30-7. PubMed ID: 15077996
[TBL] [Abstract][Full Text] [Related]
32. Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics.
Cazzola M; Calzetta L; Page C; Rogliani P; Matera MG
Trends Pharmacol Sci; 2019 Jul; 40(7):452-463. PubMed ID: 31147200
[TBL] [Abstract][Full Text] [Related]
33. Macrolide antibiotic inhibition of translation and 50S ribosomal subunit assembly in methicillin-resistant Staphylococcus aureus cells.
Champney WS; Burdine R
Microb Drug Resist; 1998; 4(3):169-74. PubMed ID: 9818968
[TBL] [Abstract][Full Text] [Related]
34. Influence of clindamycin on the stability of coa and fnbB transcripts and adherence properties of Staphylococcus aureus Newman.
Blickwede M; Wolz C; Valentin-Weigand P; Schwarz S
FEMS Microbiol Lett; 2005 Nov; 252(1):73-8. PubMed ID: 16165330
[TBL] [Abstract][Full Text] [Related]
35. Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study.
Abut E; Yaşar B; Güveli H; Bölükbaş C; Bölükbaş FF; Dalay AR; Kurdaş OO
Scand J Gastroenterol; 2010 Jun; 45(6):677-83. PubMed ID: 20334478
[TBL] [Abstract][Full Text] [Related]
36. [Sub-MIC concentrations of rokitamycin inhibit S. aureus' adhesiveness to human epithelial cells].
Braga PC; Piatti G; Allegra L
G Ital Chemioter; 1991; 38(1-3):117-8. PubMed ID: 1365561
[No Abstract] [Full Text] [Related]
37. Antibacterial activity of clarithromycin loaded PLGA nanoparticles.
Valizadeh H; Mohammadi G; Ehyaei R; Milani M; Azhdarzadeh M; Zakeri-Milani P; Lotfipour F
Pharmazie; 2012 Jan; 67(1):63-8. PubMed ID: 22393833
[TBL] [Abstract][Full Text] [Related]
38. Emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin: a randomized, double-blind, placebo-controlled study.
Berg HF; Tjhie JH; Scheffer GJ; Peeters MF; van Keulen PH; Kluytmans JA; Stobberingh EE
Antimicrob Agents Chemother; 2004 Nov; 48(11):4183-8. PubMed ID: 15504839
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of Staphylococcus aureus Adhesion to the Surface of a Reticular Heavyweight Polypropylene Mesh Soaked in a Combination of Chlorhexidine and Allicin: An In vitro Study.
Pérez-Köhler B; García-Moreno F; Bayon Y; Pascual G; Bellón JM
PLoS One; 2015; 10(5):e0126711. PubMed ID: 25962163
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial activity of erythromycin and clarithromycin against clinical isolates of Escherichia coli, Staphylococcus aureus, Klebsiella and Proteus by disc diffusion method.
Khan NW; Hassan F; Naqvi BS; Hasan SM
Pak J Pharm Sci; 2011 Jan; 24(1):25-9. PubMed ID: 21190914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
